Expert Insight on Pivotal Phase 2 Data of AMX0035 in Wolfram Syndrome

Fumihiko Urano, MD, PhD, principal investigator of the phase 2 HELIOS trial, discussed some of the notable findings from the study, as well as the potential of AMX0035 to treat patients with Wolfram syndrome.:

Source: Neurology Read More